Literature DB >> 17149531

Gigantic recurrent abdominal desmoid tumour: a case report.

E A Rakha1, M A Kandil, M G El-Santawe.   

Abstract

Deeply seated fibromatosis or desmoid tumour (DT) is a rare entity characterized by benign proliferation of fibroblasts. Although non-malignant, this tumour can be life-threatening due to its invasive property and high recurrence rate. We report a unique case of a huge recurrent abdominal DT (36 cm in diameter, 25 kg in weight) that caused pressure necrosis and sloughing of the overlying anterior abdominal wall, and produced a large fungating mass protruding outside the abdomen. Although preoperative neoadjuvant therapies were all ineffective, radical surgical removal of the tumour was successful. The procedure was followed by an excellent clinical recovery and the patient is still alive with no evidence of recurrent disease after a 6-year follow-up. We recommend surgical removal of DT regardless of its size and in particular in cases where there is no or inadequate response to neoadjuvant therapy.

Entities:  

Mesh:

Year:  2006        PMID: 17149531     DOI: 10.1007/s10029-006-0165-4

Source DB:  PubMed          Journal:  Hernia        ISSN: 1248-9204            Impact factor:   4.739


  21 in total

1.  Successful treatment of recurrent pelvic desmoid tumour with tamoxifen: case report.

Authors:  A S Chao; C H Lai; S Hsueh; C S Chen; Y C Yang; Y K Soong
Journal:  Hum Reprod       Date:  2000-02       Impact factor: 6.918

2.  Fibromatosis of the female pelvis.

Authors:  G Cormio; L Cormio; A Marzullo; F Pansini; A Traficante; F P Selvaggi; L Selvaggi
Journal:  Ann Chir Gynaecol       Date:  1997

3.  Long-term follow-up of a recurrent multifocal desmoid tumour treated with tamoxifen: a case report.

Authors:  D P Gwynne-Jones; J C Theis; A K Jeffery; N A Hung
Journal:  J Orthop Surg (Hong Kong)       Date:  2005-08       Impact factor: 1.118

4.  Recent trends in the management of desmoid tumors. Summary of 19 cases and review of the literature.

Authors:  D W Easter; N A Halasz
Journal:  Ann Surg       Date:  1989-12       Impact factor: 12.969

Review 5.  Desmoid tumour: a pleomorphic lesion.

Authors:  M N Kulaylat; C P Karakousis; C M Keaney; D McCorvey; J Bem; J L Ambrus
Journal:  Eur J Surg Oncol       Date:  1999-10       Impact factor: 4.424

6.  Desmoid tumors and their management.

Authors:  J Khorsand; C P Karakousis
Journal:  Am J Surg       Date:  1985-02       Impact factor: 2.565

Review 7.  Chemotherapy for desmoid tumours in association with familial adenomatous polyposis: a report of three cases.

Authors:  L Hamilton; M Blackstein; T Berk; R S McLeod; S Gallinger; L Madlensky; Z Cohen
Journal:  Can J Surg       Date:  1996-06       Impact factor: 2.089

8.  Sporadic hereditary pancreatic desmoid tumor: a new entity?

Authors:  Tarik Zafer Nursal; Osman Abbasoglu
Journal:  J Clin Gastroenterol       Date:  2003-08       Impact factor: 3.062

9.  The desmoid tumor. IV. Choice of treatment, results, and complications.

Authors:  J J Reitamo
Journal:  Arch Surg       Date:  1983-11

10.  Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder.

Authors:  B A Alman; M E Pajerski; S Diaz-Cano; K Corboy; H J Wolfe
Journal:  Diagn Mol Pathol       Date:  1997-04
View more
  3 in total

1.  Giant mesenteric fibromatosis: Report of a case and review of the literature.

Authors:  Mohammed Khalid Mirza Gari; Salman Yousuf Guraya; Amir Mounir Hussein; Moustafa Mahmoud Nafady Hego
Journal:  World J Gastrointest Surg       Date:  2012-03-27

2.  A giant mesenteric desmoid tumor revealed by acute pulmonary embolism due to compression of the inferior vena cava.

Authors:  Elisa Palladino; Joseph Nsenda; Renaud Siboni; Christian Lechner
Journal:  Am J Case Rep       Date:  2014-09-02

3.  Duodenum-derived fibromatosis that invaded the muscular layer of intestinal wall: A rare case report.

Authors:  Jiannan Li; Hanxiang Le; Wei Chai; Yan Zhou; Lifang Jin; Tongjun Liu; Kai Zhang
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.